Search

Your search keyword '"Yoshimura, Sohei"' showing total 403 results

Search Constraints

Start Over You searched for: Author "Yoshimura, Sohei" Remove constraint Author: "Yoshimura, Sohei"
403 results on '"Yoshimura, Sohei"'

Search Results

2. Thrombolysis for Wake-Up Stroke Versus Non–Wake-Up Unwitnessed Stroke: EOS Individual Patient Data Meta-Analysis

9. Clinical impact of body mass index on outcomes of ischemic and hemorrhagic strokes.

12. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

15. Abstract WP19: Is Direct Oral Anticoagulant More Effective Than Warfarin to Reduce Size of Left Atrial Thrombus in Stroke Patients?

16. Abstract WP167: Clinical Characteristics and Outcomes of Mixed Cerebral Small Vessel Disease According to the CLAS-ICH Classification

17. Abstract WP21: Intravenous Alteplase for Unknown Onset Stroke on Prior Antiplatelet Therapy: EOS Individual Participant Data

18. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

19. Cerebral Small Vessel Disease Burden for Bleeding Risk during Antithrombotic Therapy: Bleeding with Antithrombotic Therapy 2 Study.

23. Magnetic Resonance Imaging–Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT Substudy

25. Association of the Timing of Atrial Fibrillation Detection and Insular Involvement With the Risk of Embolic Events After Acute Ischemic Stroke.

26. Thrombolysis for Acute Wake-Up and Unclear-Onset Strokes with Alteplase at 0.6 mg/kg in Clinical Practice: THAWS2 Study.

28. Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial

30. Early Initiation of Direct Oral Anticoagulants After Onset of Stroke and Short- and Long-Term Outcomes of Patients With Nonvalvular Atrial Fibrillation

35. Abstract 3: Cerebral Small Vessel Disease Burden For Bleeding Risk During Antithrombotic Therapy -BAT2-

37. Abstract WP88: Discrepant Nationwide Trends In Outcomes Of Acute Ischemic Stroke Depending On Severity: The Japan Stroke Data Bank

38. Abstract TMP2: Intravenous Thrombolysis For Ischemic Stroke With Unknown Time Of Onset: Differences Between Wake-up Stroke And Non-wake-up Subtypes: EOS

40. Sequential Detection Rates of Intramural Hematoma for Diagnosing Spontaneous Intracranial Artery Dissection

41. Severity, Outcomes, and Their Secular Changes in 33,870 Ischemic Stroke Patients with Atrial Fibrillation in a Long-Lasting, Nationwide, Hospital-Based Registry

45. Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical Trial

46. Atrial Fibrillation Detected before or after Stroke:Role of Anticoagulation

47. IC methods in acute stroke trials-ascoping review

48. Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation

49. Alteplase for Stroke With Unknown Onset Time in Chronic Kidney Disease: A Pooled Analysis of Individual Participant Data

50. Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants

Catalog

Books, media, physical & digital resources